Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul C Langley
Rush to Judgement: Imaginary Worlds and Cost-Outcomes Claims for PCSK9 Inhibitors
INNOVATIONS in pharmacy
Imaginary Worlds: The Status of Modeled Quality Adjusted Life Year Claims for New Oral Anticoagulants in Atrial Fibrillation Published Between January 2012 and February 2016
INNOVATIONS in pharmacy
Related publications
Are PCSK9 Inhibitors Cost Effective?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Reproductive Cloning: Don't Rush to Judgement
Nature
Multidisciplinary
PCSK9 Peptide Inhibitors
Science-Business eXchange
Cost Effectiveness of Proprotein Convertase Subtilisin/ Kexin Type 9 (PCSK9) Inhibitors
Cardiovascular Disorders and Medicine
PCSK9 Inhibitors: A Technology Worth Paying For?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Validating Imaginary Worlds? The AdViSHE Assessment Tool
INNOVATIONS in pharmacy
PCSK9 Inhibitors: When Statins Aren't Enough
Prescriber
Pharmacology
Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice
Postgraduate Medicine
Medicine
